BANQUE PICTET & CIE SA

Position in PCVX — Vaxcyte, Inc.

CIK 1535602 GENEVA 73, V8

Position in PCVX

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$2,600,503

-$993,368 QoQ

Shares Held

44,736

-27.7% QoQ

Ownership

0.030%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#124

of 330 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BANQUE PICTET & CIE SA holds $213,407,213 across 8 Biotechnology names. PCVX ranks #3 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc.	2,699,402	$189,039,122
2	VRTX	Vertex Pharmaceuticals Inc / Ma	23,496	$11,671,168
3	PCVX	Vaxcyte, Inc. This page	44,736	$2,600,503
4	GPCR	Structure Therapeutics Inc.	43,332	$2,325,628
5	REGN	Regeneron Pharmaceuticals, Inc.	3,713	$2,315,204
6	IMVT	Immunovant, Inc.	57,190	$2,203,530
7	BNTX	BioNTech SE	17,705	$1,647,450
8	AVIR	Atea Pharmaceuticals, Inc.	345,077	$1,604,608

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,600,503	44,736	-27.7%	Shares	Sole	2026-07-24
2026-03-31	$3,593,871	61,846	-13.9%	Shares	Sole	2026-04-14
2025-12-31	$3,313,544	71,815	-4.1%	Shares	Sole	2026-01-16
2025-09-30	$2,696,601	74,864	-10.2%	Shares	Sole	2025-10-21
2025-06-30	$2,710,423	83,372	+43.8%	Shares	Sole	2025-07-16
2025-03-31	$2,189,211	57,977	-2.3%	Shares	Sole	2025-04-30
2024-12-31	$4,855,525	59,315	-8.4%	Shares	Sole	2025-01-30
2024-09-30	$7,401,496	64,772	+9.6%	Shares	Sole	2024-10-21
2024-06-30	$4,460,904	59,077	-3.0%	Shares	Sole	2024-07-25
2024-03-31	$4,159,190	60,887	—	Shares	Sole	2024-05-06
No filing history on record for this holder in this stock.